Corline Biomedical AB (CLBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
32
About the Report
About the Report
Summary
Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytoparin for cell therapy and diabetes type 1, and renaparin for kidney transplantation. Corline Biomedical offers CHC based on pre-assembled aggregates of heparin molecules. The company also provides surface coatings. It partners with medical device companies to improve blood and biocompatibility of medical device implants. Corline Biomedical is headquartered in Uppsala, Sweden.
Corline Biomedical AB (CLBIO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Corline Biomedical AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corline Biomedical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Corline Biomedical to Enter into Agreement with University of Alberta 10
Corline Biomedical to Enter into Agreement with Nuffield Department of Surgical Sciences 11
Equity Offering 12
Corline Biomedical Raises USD1.31 Million in Rights Offering of Shares 12
Corline Biomedical Raises USD1.88 Million in Rights offering of Shares 13
Corline Biomedical Raises USD3 Million in Rights offering of Shares 15
Corline Biomedical Raises USD8.73 Million in Initial Public Offering of Shares 16
Corline Biomedical AB-Key Competitors 17
Corline Biomedical AB-Key Employees 18
Corline Biomedical AB-Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Aug 23, 2018: Corline Biomedical publishes interim report for the first half of 2018 20
May 17, 2018: Corline Biomedical publishes interim report for the first quarter of 2018 22
Feb 22, 2018: Corline Biomedical publishes the year-end report for 2017 23
Nov 16, 2017: Corline Biomedical publishes the interim report for January-September 2017 25
Aug 23, 2017: Corline Biomedical: Announces interim report for the period January-June 2017 27
May 18, 2017: Corline Biomedical publishes the interim report for January to March 2017 29
Feb 23, 2017: Corline Biomedical publishes year-end report for January-December 2016 30
Corporate Communications 31
Apr 03, 2017: Corline Biomedical: Further expertise and networking is provided to the Board 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Figure
List of Figures
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Corline Biomedical AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corline Biomedical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corline Biomedical AB, Deals By Therapy Area, 2012 to YTD 2018 8
Corline Biomedical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Corline Biomedical to Enter into Agreement with University of Alberta 10
Corline Biomedical to Enter into Agreement with Nuffield Department of Surgical Sciences 11
Corline Biomedical Raises USD1.31 Million in Rights Offering of Shares 12
Corline Biomedical Raises USD1.88 Million in Rights offering of Shares 13
Corline Biomedical Raises USD3 Million in Rights offering of Shares 15
Corline Biomedical Raises USD8.73 Million in Initial Public Offering of Shares 16
Corline Biomedical AB, Key Competitors 17
Corline Biomedical AB, Key Employees 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.